title: Late dofetilide-associated life-threatening proarrhythmia.
abstract: This report is about a 62-year old male patient with an implantable cardioverter defibrillator (ICD) for patient activated termination of atrial fibrillation who experienced dofetilide-associated ventricular tachyarrhythmias and ICD-induced ventricular fibrillation six months after the initiation of the antiarrhythmic drug therapy.
authors.forename: Christof
authors.initials: C
authors.lastname: Kolb
authors.forename: Gjin
authors.initials: G
authors.lastname: Ndrepepa
authors.forename: Bernhard
authors.initials: B
authors.lastname: Zrenner
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000628:therapy*; D017147:Defibrillators, Implantable / Q000009:adverse effects*; D004562:Electrocardiography; D006801:Humans; D008297:Male; D008875:Middle Aged; D010627:Phenethylamines / Q000009:adverse effects*; D013449:Sulfonamides / Q000009:adverse effects*; D017180:Tachycardia, Ventricular / Q000139:chemically induced*; D014693:Ventricular Fibrillation / Q000209:etiology*
chemical_list: D000889:Anti-Arrhythmia Agents; D010627:Phenethylamines; D013449:Sulfonamides; C063533:dofetilide